Medical Condition News

RSS

Lost sleep and jangled nerves: The rising onslaught of noise harms mind and body

Mike Thomson's friends refuse to stay over at his house anymore. Thomson lives about 50 yards from a busy freeway that bisects California's capital city, one that has been increasingly used as a speedway for high-speed races, diesel-spewing big rigs, revving motorcycles — and cars that have been illegally modified to make even more noise.

5 Jan 2023

Study links sugary drinks to male hair loss

A new Nutrients journal study explored the association between sugar-sweetened beverage (SSB) consumption and MPHL in young men in China.

4 Jan 2023

Experts seek to understand risks associated with vaping and e-cigarettes

E-cigarette or vaping product use–associated lung injury (EVALI) is a severe pulmonary illness caused by using e-cigarettes or vaping products. In the United States, in 2018, an alarming 25% of youth adopted e-cigarettes, with the overall number being more than 13 million individuals.

4 Jan 2023

New project seeks to develop an online driver safety test for people with dementia

University of Queensland researchers are working with people living with dementia to develop an online driver safety test that can be performed by GPs in their surgeries.

4 Jan 2023

Mediterranean diet may benefit health in part by incorporating moderate wine consumption

Many public health warnings have been issued against alcohol consumption, even in small quantities, though the evidence for such strict limits is controversial. The current study, published in the MDPI journal Nutrients, is a narrative review focused on clearing up some of the confusion associated with alcoholic drinks.

4 Jan 2023

Early intervention key to managing diabetes, cardiorenal, and metabolic diseases

A panel of US-based experts in cardiology, nephrology, endocrinology, and primary care has prepared specific recommendations for early identification and intervention in obesity, diabetes, and other cardiorenal and metabolic diseases. A detailed report on recommended strategies has been published in the Journal of Diabetes and its Complications.

4 Jan 2023

Incurable liver disease could be reversed with a single drug

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the liver, could be reversed with a single drug.

4 Jan 2023

Study shows the potential of a game-changing drug to treat upper urinary tract urothelial cancers

A team from 15 U.S. medical centers led by UT Southwestern Simmons Cancer Center researchers has performed the first analysis of a potentially game-changing drug to treat upper urinary tract urothelial cancers.

4 Jan 2023

New dual-action, cancer-killing vaccine tested in an advanced mouse model of glioblastoma

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, investigators have developed a new cell therapy approach to eliminate established tumors and induce long-term immunity, training the immune system so that it can prevent cancer from recurring.

4 Jan 2023

Researchers discover novel candidate drug targets for advanced non-alcoholic fatty liver disease

Using the latest technologies - including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells - researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD).

4 Jan 2023

Distinct genomic patterns of malignant peripheral nerve sheath tumors may help with early diagnosis

Neurofibromatosis type 1 (NF1) is a common genetic condition, affecting 1 in 3000 individuals, and people with NF1 are at greater risk of developing a rare, aggressive form of cancer.

4 Jan 2023

Research offers a cost-effectiveness analysis of anticoagulant drugs for cancer-associated thrombosis

Newly published research out of the University of Cincinnati and the University of California-Davis shows that direct oral anticoagulant (DOAC) drugs are more effective and are more cost-effective than low molecular weight heparin for treating cancer-associated thrombosis.

4 Jan 2023

Medical Condition News

Lost sleep and jangled nerves: The rising onslaught of noise harms mind and body

Study links sugary drinks to male hair loss

Experts seek to understand risks associated with vaping and e-cigarettes

New project seeks to develop an online driver safety test for people with dementia

Mediterranean diet may benefit health in part by incorporating moderate wine consumption

Early intervention key to managing diabetes, cardiorenal, and metabolic diseases

Incurable liver disease could be reversed with a single drug

Study shows the potential of a game-changing drug to treat upper urinary tract urothelial cancers

New dual-action, cancer-killing vaccine tested in an advanced mouse model of glioblastoma

Researchers discover novel candidate drug targets for advanced non-alcoholic fatty liver disease

Distinct genomic patterns of malignant peripheral nerve sheath tumors may help with early diagnosis

Research offers a cost-effectiveness analysis of anticoagulant drugs for cancer-associated thrombosis

Dietary supplement can reverse the signs of heart disease in a subset of patients

The interrelationship between diet, physical health, and depression

The metabolic links between diet-induced changes in the gut and NASH

High burden of multi-food allergies among children and adults in the U.S.

Precise 3D imaging can help measure radiation during cancer treatment

Novel triple immunotherapy combination improves anti-tumor responses in preclinical models of pancreatic cancer

Traditional Chinese medicine may help treat neurodegenerative diseases caused by HSV-1 reactivation

The role of exosomes in osteosarcoma diagnosis, prognosis, and therapeutics

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News